Cerovac, V., Monteserin, J. L., Stalla, G. K., & Theodoropoulou, M. (2009). Octreotide enhances rapamycin's antiproliferative action by inhibiting rapamycin-induced IRS-1 and Akt activation. Experimental and Clinical Endocrinology & Diabetes, 117(10), 657-657.